Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-28

Clinical Trial Update: A Study of Teriparatide in Japanese Osteoporosis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating teriparatide in Japanese osteoporosis patients has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Forteo) (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2012-12-28